Home › Funds › Venrock Adviser, LLC › ORIC
Venrock Adviser, LLC position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
Venrock Adviser, LLC reported holding 2,944,056 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$39.7M, representing 1.93% of its reported portfolio and ranking #16 among its reported holdings. Venrock Adviser, LLC has disclosed ORIC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's ORIC position evolved
Venrock Adviser, LLC first disclosed a stake in ORIC in Q3 2023 at 2,142,856 shares (US$13.0M). The position peaked in Q3 2025 at 6,596,885 shares, worth US$79.2M. Across 13 filings, Venrock Adviser, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 2,944,056 shares valued at US$39.7M — a reduction of -1,375,709 shares quarter over quarter.. Notable position changes include a 81% increase in Q1 2024 (shares fell 49% over the following quarter), a 107% increase in Q2 2025 (shares rose 18% over the following quarter), a 32% trim in Q3 2026 (shares fell 44% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.14M | $12.96M | New |
| Q4 2023 | 2.43M | $22.34M | Add |
| Q1 2024 | 4.39M | $60.42M | Add |
| Q2 2024 | 4.39M | $31.07M | Hold |
| Q3 2024 | 4.39M | $45.04M | Hold |
| Q4 2024 | 4.39M | $35.46M | Hold |
| Q1 2025 | 3.18M | $17.76M | Reduce |
| Q2 2025 | 6.60M | $66.96M | Add |
| Q3 2025 | 6.60M | $79.16M | Hold |
| Q4 2025 | 5.68M | $46.43M | Reduce |
| Q1 2026 | 4.32M | $54.73M | Reduce |
| Q2 2026 | 4.32M | $46.78M | Hold |
| Q3 2026 | 2.94M | $39.66M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$96.5M), AIHC Capital Management Ltd (US$62.4M), SR ONE CAPITAL MANAGEMENT, LP (US$62.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- Nextech Invest Ltd. 7.16M sh · $96.48M · Q3 2026
- AIHC Capital Management Ltd 4.63M sh · $62.38M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M sh · $62.17M · Q3 2026
- NEA Management Company, LLC 4.12M sh · $55.48M · Q3 2026
- Column Group LLC 3.54M sh · $47.69M · Q3 2026
- Siren, L.L.C. 3.36M sh · $45.23M · Q3 2026
- EcoR1 Capital, LLC 3.03M sh · $40.79M · Q3 2026
- Defilade Capital Management, L.P. 2.27M sh · $30.61M · Q3 2026
- MPM BioImpact LLC 1.82M sh · $24.54M · Q3 2026
- First Turn Management, LLC 1.57M sh · $21.21M · Q3 2026
- ORBIMED ADVISORS LLC 1.56M sh · $20.96M · Q3 2026
- Paradigm Biocapital Advisors LP 1.51M sh · $20.28M · Q3 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held ORIC?
Venrock Adviser, LLC has disclosed ORIC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Venrock Adviser, LLC's current position in ORIC?
As of Q3 2026, Venrock Adviser, LLC holds 2.94M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $39.66M, representing 1.93% of its reported portfolio and ranking #16.
Has Venrock Adviser, LLC been buying or selling ORIC?
In the latest 13F filing (Q3 2026), Venrock Adviser, LLC reduced its position in ORIC. The position peaked in Q3 2025 at 6.60M shares.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., AIHC Capital Management Ltd, SR ONE CAPITAL MANAGEMENT, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.